One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...

Laboratory of Human Genetics & Therapeutics, Smart Health Initiative, Division of Biological and Environmental Science and Engineering (BESE), King Abdullah University of Science and Technology (KAUST ...

Secondary endpoints in the MINDFuL trial include the CDR-SB, E-Cog, ADL and Neuropsychiatric Inventory (NPI) instruments, along with blood biomarker and neuroimaging outcomes. Baseline demographics, ...

INmune Bio (INMB) is presenting a poster at the annual International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic ...

Brian Tait, Chief Scientific Officer at Haplomic Technologies Pty Ltd, focuses here on CYP genes, haplotypes, and their ...

Douglas A. Tremblay, MD, discusses the long-term data supporting ropeginterferon alfa-2b-njft as treatment in patients with polycythemia vera.

In the US, where Kisunla was approved last year, the Food and Drug Administration required a boxed warning on Kisunla's label, in which it recommends genetic testing to assess whether a patient ...

A recent study released by the University of Wisconsin-Madison sheds light on how the sugary enhancer1 (se1) allele influences the nutritional profile ...

In testing, adults with mild cognitive impairment score lower on a simple smell test than adults with normal cognitive ...